BSE filing, NSE: ARFIN. Summary written from the filing by ALFA Finder's alert engine.
Arfin India Ltd: key numbers
- Share price
- ₹89.68
- Market cap
- ₹1,513 Cr
- Revenue (annual)
- ₹618.0 Cr
- Net profit (annual)
- ₹15.45 Cr
- P/E (TTM)
- 82.0×Sector 16.7×
- Promoter holding
- 69.77%+0.00% QoQ
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arfin India Ltd
All →Arfin India Board Meeting Date
Arfin India Limited intimated that its Board of Directors will meet on 3 November 2026. The agenda includes considering unaudited financial results for the quarter and half year ended 30 September 2026.
Arfin India Other Announcement
This filing provides the quarterly shareholding pattern for Arfin India Ltd as required by SEBI regulations. No material corporate event or business transaction is included.
Arfin India Annual General Meeting
Arfin India Limited held its 34th Annual General Meeting on September 19, 2026. All proposed ordinary and special resolutions were passed with the requisite votes.
Arfin India Dividend
Arfin India's board declared an interim dividend of Rs 0.12 per equity share for FY 2026-27. Record date is fixed for September 24, 2026.
Arfin India Promoter Buying (Off-Market)
Promoter Mahendrakumar Rikhavchand Shah will acquire shares from two other promoters via an off-market inter-se gift transfer, increasing his stake by 5.77%.
Arfin India Other Announcement
Arfin India Limited has dispatched physical letters to shareholders without registered email addresses. The letter provides web links for the FY 2025-26 Annual Report and AGM notice.
Other board meeting date announcements
All →HCP Plastene Bulkpack Board Meeting Date
HCP Plastene Bulkpack scheduled a board meeting for 06 November 2026. It will consider unaudited results for the quarter and half year ending 30 September 2026.
Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.